Characteristics of Patients With Asymptomatic Atrial Fibrillation and Ischemic Stroke—Insights From the GLORIA‐AF Registry (Phase 2)
aAF is reported in about one third of patients with newly diagnosed AF and is associated with a 2.3-fold risk for stroke compared to sAF. Therefore, screening for aAF in high-risk patients might be appropriate to prevent further embolic cerebrovascular events.
Authors
- Christopher Jan Schwarzbach (ORCID: https://orcid.org/0000-0003-3539-3345)
- Menno V. Huisman (ORCID: https://orcid.org/0000-0003-1423-5348)
- Sabrina Marler (ORCID: https://orcid.org/0000-0002-9912-4024)
- Christine Teutsch (ORCID: https://orcid.org/0000-0002-8494-2876)
- K. Seidl
- Gregory Y.H. Lip (ORCID: https://orcid.org/0000-0002-7566-1626)
- Jochen Senges (ORCID: https://orcid.org/0009-0001-3547-2126)
- Uwe Zeymer (ORCID: https://orcid.org/0000-0001-7077-283X)
- Tobias Heer (ORCID: https://orcid.org/0000-0003-1547-9918)
- Hans‐Christoph Diener
- Ursula Rauch‐Kröhnert
Institutions
- Boehringer Ingelheim (Germany) (DE)
- University of Liverpool (GB)
- Leiden University Medical Center (NL)
- Institut für Medizinische Informatik, Biometrie und Epidemiologie (DE)
- Liverpool Heart and Chest Hospital (GB)
- Westpfalz Klinikum (DE)
- Stiftung Institut für Herzinfarktforschung (DE)
- Klinikum Ludwigshafen (DE)
- München Klinik Neuperlach (DE)
- Boehringer Ingelheim (United States) (US)
- Liverpool John Moores University (GB)
- Charité - Universitätsmedizin Berlin (DE)
- Ludwig-Maximilians-Universität München (DE)
- Aalborg University (DK)
Publication Details
- Journal
- Pacing and Clinical Electrophysiology
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1111/pace.15113
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Boehringer Ingelheim